메뉴 건너뛰기




Volumn 7, Issue 22, 2016, Pages 32925-32932

Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers

Author keywords

EBV infected gastric cancers; MSI gastric cancer; PD 1 inhibitors; PD L1

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1; CD274 PROTEIN, HUMAN; GAMMA INTERFERON;

EID: 84973559133     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9076     Document Type: Article
Times cited : (246)

References (24)
  • 2
    • 84973581304 scopus 로고    scopus 로고
    • Multicohort phase II KEYNOTE-059 study of pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
    • abstr TPS4135
    • Charles S. Fuchs, Andrew E. Denker, Josep Tabernero, Eric Van Cutsem, Atsushi Ohtsu, Baohoang Lam, Minori Koshiji, Bang Y-J. Multicohort phase II KEYNOTE-059 study of pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. J Clin Oncol. 2015; 33:(suppl; abstr TPS4135).
    • (2015) J Clin Oncol , vol.33
    • Fuchs, C.S.1    Denker, A.E.2    Tabernero, J.3    Van Cutsem, E.4    Ohtsu, A.5    Lam, B.6    Koshiji, M.7    Bang, Y.-J.8
  • 4
    • 84907270779 scopus 로고    scopus 로고
    • Comprehensive molecular characterization of gastric adenocarcinoma
    • Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513:202-209.
    • (2014) Nature , vol.513 , pp. 202-209
  • 6
    • 84941797037 scopus 로고    scopus 로고
    • Classifying Cancers Based on T-cell Infiltration and PD-L1
    • Teng MW, Ngiow SF, Ribas A, Smyth MJ. Classifying Cancers Based on T-cell Infiltration and PD-L1. Cancer Res. 2015; 75:2139-2145.
    • (2015) Cancer Res , vol.75 , pp. 2139-2145
    • Teng, M.W.1    Ngiow, S.F.2    Ribas, A.3    Smyth, M.J.4
  • 8
    • 84997787368 scopus 로고    scopus 로고
    • The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
    • Romano E, Romero P. The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors. J Immunother Cancer. 2015; 3:15.
    • (2015) J Immunother Cancer , vol.3 , pp. 15
    • Romano, E.1    Romero, P.2
  • 9
    • 23244448471 scopus 로고    scopus 로고
    • EBV the prototypical human tumor virus-just how bad is it?
    • quiz 262.
    • Thorley-Lawson DA. EBV the prototypical human tumor virus-just how bad is it? J Allergy Clin Immunol. 2005; 116:251-261; quiz 262.
    • (2005) J Allergy Clin Immunol , vol.116 , pp. 251-261
    • Thorley-Lawson, D.A.1
  • 12
    • 84858206832 scopus 로고    scopus 로고
    • Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy
    • Green MR, Rodig S, Juszczynski P, Ouyang J, Sinha P, O'Donnell E, Neuberg D, Shipp MA. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res. 2012; 18:1611-1618.
    • (2012) Clin Cancer Res , vol.18 , pp. 1611-1618
    • Green, M.R.1    Rodig, S.2    Juszczynski, P.3    Ouyang, J.4    Sinha, P.5    O'Donnell, E.6    Neuberg, D.7    Shipp, M.A.8
  • 13
    • 0842325739 scopus 로고    scopus 로고
    • PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells
    • Blank C, Brown I, Peterson AC, Spiotto M, Iwai Y, Honjo T, Gajewski TF. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 2004; 64:1140-1145.
    • (2004) Cancer Res , vol.64 , pp. 1140-1145
    • Blank, C.1    Brown, I.2    Peterson, A.C.3    Spiotto, M.4    Iwai, Y.5    Honjo, T.6    Gajewski, T.F.7
  • 15
    • 84968919518 scopus 로고    scopus 로고
    • Dual faces of IFN-gamma in cancer progression: a role of PD-L1 induction in the determination of pro- and anti-tumor immunity
    • Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Dual faces of IFN-gamma in cancer progression: a role of PD-L1 induction in the determination of pro- and anti-tumor immunity. Clin Cancer Res. 2016.
    • (2016) Clin Cancer Res
    • Mandai, M.1    Hamanishi, J.2    Abiko, K.3    Matsumura, N.4    Baba, T.5    Konishi, I.6
  • 16
    • 0033178448 scopus 로고    scopus 로고
    • Initial and innate responses to viral infections- pattern setting in immunity or disease
    • Biron CA. Initial and innate responses to viral infections- pattern setting in immunity or disease. Curr Opin Microbiol. 1999; 2:374-381.
    • (1999) Curr Opin Microbiol , vol.2 , pp. 374-381
    • Biron, C.A.1
  • 21
    • 33644827779 scopus 로고    scopus 로고
    • Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection
    • Chiaravalli AM, Feltri M, Bertolini V, Bagnoli E, Furlan D, Cerutti R, Novario R, Capella C. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch. 2006; 448:344-353.
    • (2006) Virchows Arch , vol.448 , pp. 344-353
    • Chiaravalli, A.M.1    Feltri, M.2    Bertolini, V.3    Bagnoli, E.4    Furlan, D.5    Cerutti, R.6    Novario, R.7    Capella, C.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.